MARKET

IVVD

IVVD

Invivyd
NASDAQ
0.5626
+0.0196
+3.61%
Opening 11:46 07/30 EDT
OPEN
0.5567
PREV CLOSE
0.5430
HIGH
0.5814
LOW
0.5517
VOLUME
852.56K
TURNOVER
--
52 WEEK HIGH
3.070
52 WEEK LOW
0.4830
MARKET CAP
165.75M
P/E (TTM)
-1.5750
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IVVD last week (0720-0724)?
Weekly Report · 3d ago
Invivyd Receives Nasdaq Notice for Bid Price Deficiency
TipRanks · 5d ago
Invivyd gets Nasdaq notice after shares trade below $1 minimum bid price
PUBT · 6d ago
Weekly Report: what happened at IVVD last week (0713-0717)?
Weekly Report · 07/20 09:38
Weekly Report: what happened at IVVD last week (0706-0710)?
Weekly Report · 07/13 09:39
Analysts Conflicted on These Healthcare Names: Cipher Pharmaceuticals (OtherCPHRF), Invivyd (IVVD) and Merck & Company (MRK)
TipRanks · 07/09 12:40
Invivyd: Buy Rating Reiterated as PEMGARDA EUA Transition Seen as Administrative; $10 Price Target Unchanged
TipRanks · 07/08 10:15
Invivyd Price Target Maintained With a $10.00/Share by BTIG
Dow Jones · 07/07 09:48
More
About IVVD
Invivyd, Inc. is a biopharmaceutical company. The Company’s proprietary INVYMAB platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to keep pace with evolving viral threats. The Company delivers antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, such as SARS-CoV-2. Its PEMGARDA (pemivibart) is the Company's first mAb to receive regulatory authorization and is designed to keep pace with SARS-CoV-2 viral evolution. PEMGARDA is used for the pre-exposure prophylaxis (prevention) of COVID-19 in adults and adolescents. Its VYD2311 is optimized for neutralization potency against SARS-CoV-2 lineages such as BA.2.86 and JN.1. The Company also has additional anti-SARS-CoV-2 mAb candidates in discovery and pre-clinical characterization.

Webull offers Invivyd Inc stock information, including NASDAQ: IVVD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IVVD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IVVD stock methods without spending real money on the virtual paper trading platform.